Sharing the vast expertise at UNC-Chapel Hill and learning from researchers at other institutions is critical to creating a better future for North Carolina. That includes everything from the NC TraCS Institute, a translational sciences partnership with NC State and North Carolina Agricultural and Technical State University, to the Triangle Universities Nuclear Laboratory, where researchers from Carolina, NC State and NC Central work with Duke University to advance the frontiers of nuclear physics and educate the next generation of scientists.

The joint effort has also developed technology for startups like SonoVascular, a med-tech company that combines drug-based and mechanical therapies to treat blood clots in a unique way. The work is a product of a long-running research collaboration between Xiaoning Jiang, Dean F. Duncan Distinguished Professor in the NC State University Department of Mechanical and Aerospace Engineering, and Paul Dayton, William R. Kenan Distinguished Professor and Chair of the BME. They serve as scientific advisers to SonoVascular.